BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/13/2020 9:39:45 PM | Browse: 171 | Download: 438
Category |
Critical Care Medicine |
Manuscript Type |
Observational Study |
Article Title |
Experience with hemoadsorption (CytoSorb<sup>®</sup>) in the management of septic shock patients
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Yatin Mehta, Chitra Mehta, Ashish Kumar, Joby V George, Aditi Gupta, Saurabh Nanda, Gaurav Kochhar and Arun Raizada |
Funding Agency and Grant Number |
|
Corresponding Author |
Yatin Mehta, FRCA, MD, MNAMS, Doctor, Institute of Critical care and Anesthesia, Medanta The Medicity, Sector 38, Gurgaon 122006, Haryana, India. yatin.mehtacriticalcare@gmail.com |
Key Words |
Hemoadsorption; Sepsis; Cytokines; Clinical conditions; Inflammation and extracorporeal; |
Core Tip |
CytoSorb® is a promising new extracorporeal cytokine hemoadsorption device that can modulate the cytokine storm during sepsis. This retrospective study evaluated clinical outcomes after CytoSorb® therapy of 100 patients admitted to intensive care unit with sepsis. We observed a significant reduction in vasopressors dosage in 40 patients who survived. The survivors also had a reduction in all the biomarker levels (procalcitonin, C-reactive protein, serum lactate and bilirubin) and inflammatory markers (interleukin 6, interleukin 10 and tumour necrosis factor) after CytoSorb® therapy. Notably, 28% of patients who were given CytoSorb® therapy < 48 h after onset of septic shock survived. |
Citation |
Mehta Y, Mehta C, Kumar A, George JV, Gupta A, Nanda S, Kochhar G, Raizada A. Experience with hemoadsorption (CytoSorb®) in the management of septic shock patients. World J Crit Care Med 2020; 9(1): 1-12 |
|
Received |
|
2019-10-11 11:38 |
|
Peer-Review Started |
|
2019-10-11 11:38 |
|
To Make the First Decision |
|
2019-11-04 00:32 |
|
Return for Revision |
|
2019-11-05 00:24 |
|
Revised |
|
2019-12-23 15:06 |
|
Second Decision |
|
2020-01-13 10:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-01-13 21:39 |
|
Articles in Press |
|
2020-01-13 21:39 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-01-16 09:05 |
ISSN |
2220-3141(online) |
Open Access |
|
Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345